Compounds > n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride
Page last updated: 2024-09-03

n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and adamantane

n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with adamantane in 1 studies

Compound Research Comparison

Studies
(n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride)		Trials
(n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride)		Recent Studies (post-2010)
(n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride)		Studies
(adamantane)		Trials
(adamantane)		Recent Studies (post-2010) (adamantane)
980293,4493601,790

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bucolo, C; Caputi, A; Cuzzocrea, S; Drago, F; Marrazzo, A; Mazzon, E; Ronsisvalle, G; Ronsisvalle, S1

Other Studies

1 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and adamantane

ArticleYear
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors.
    European journal of pharmacology, 2006, Apr-24, Volume: 536, Issue:1-2

    Topics: Adamantane; Adenosine Triphosphate; Animals; Anisoles; Glucose; Lactic Acid; Male; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Reperfusion Injury; Retina; Retinal Diseases

2006